debrisoquin and acetaminophen

debrisoquin has been researched along with acetaminophen in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19905 (45.45)18.7374
1990's2 (18.18)18.2507
2000's2 (18.18)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Idle, JR; Sloan, TP; Smith, RL; Wakile, LA1
Idle, JR; Lancaster, R; Mahgoub, A; Sloan, TP; Smith, RL1
McLean, S; Veronese, ME1
Heafield, MT; Steventon, GB; Sturman, S; Waring, RH; Williams, AC1
Park, BK1
Adams, D; Pall, HS; Steventon, G; Waring, RH; Williams, AC1
Cooper, M; Devonshire, HW; Idle, JR; Kong, I; Sloan, TP; Smith, RL1

Other Studies

11 other study(ies) available for debrisoquin and acetaminophen

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Genetic evidence for the involvement of different oxidative mechanisms in drug oxidation.
    The Journal of pharmacy and pharmacology, 1979, Volume: 31, Issue:5

    Topics: Acetaminophen; Acetanilides; Adult; Debrisoquin; Genetics; Guanidines; Humans; Hydroxylation; Kinetics; Male; Oxidation-Reduction; Pharmaceutical Preparations; Phenotype

1979
Polymorphism of carbon oxidation of drugs and clinical implications.
    British medical journal, 1978, Sep-02, Volume: 2, Issue:6138

    Topics: Acetaminophen; Carbon; Debrisoquin; Female; Guanidines; Humans; Hydroxylation; Male; Oxidation-Reduction; Phenacetin; Phenotype; Polymorphism, Genetic

1978
Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.
    European journal of clinical pharmacology, 1991, Volume: 40, Issue:6

    Topics: Acetaminophen; Adult; Biotransformation; Debrisoquin; Female; Humans; Male; Oxidation-Reduction; Phenacetin; Phenotype

1991
Xenobiotic metabolism in Alzheimer's disease.
    Neurology, 1990, Volume: 40, Issue:7

    Topics: Acetaminophen; Adolescent; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Carbocysteine; Debrisoquin; Female; Humans; Male; Methyltransferases; Middle Aged; Sulfamethazine; Xenobiotics

1990
Metabolic basis of adverse drug reactions.
    Journal of the Royal College of Physicians of London, 1986, Volume: 20, Issue:3

    Topics: Acetaminophen; Acetylation; Adrenergic beta-Antagonists; Adult; Age Factors; Child; Debrisoquin; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Enzyme Induction; Enzyme Inhibitors; Humans; Perhexiline; Pharmaceutical Preparations; Phenacetin; Phenformin; Phenotype; Polymorphism, Genetic; Succinylcholine

1986
Xenobiotic metabolism in motor neuron disease.
    Lancet (London, England), 1988, Sep-17, Volume: 2, Issue:8612

    Topics: Acetaminophen; Adult; Aged; Carbocysteine; Debrisoquin; Humans; Middle Aged; Motor Neurons; Neuromuscular Diseases; Oxidation-Reduction

1988
The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition.
    British journal of clinical pharmacology, 1983, Volume: 16, Issue:2

    Topics: Acetaminophen; Adult; Dealkylation; Debrisoquin; Female; Humans; Hydroxylation; Male; Oxidation-Reduction; Phenacetin; Phenotype; Time Factors

1983